课题基金 / 基金详情

Targeting the translesion synthesis pathway as a potential therapeutic strategy in chemoresistant and late stage cancers

Targeting the translesion synthesis pathway as a potential therapeutic strategy in chemoresistant and late stage cancers
靶向跨损伤合成途径作为化疗耐药和晚期癌症的潜在治疗策略
批准号：
495243
负责人：
White Justin M
金额：
$0.11万
依托单位：
BC Cancer, part of PHSA (Vancouver)
依托单位国家：
加拿大
项目类别：
财政年份：
2023
资助国家：
加拿大
项目状态：
已结题
起止时间：
2023-10-01 至 2024-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=495243&lang=en
关键词：
Cancer Therapy Chemoresistance Dna Repair Ics Travel Awards Synthetic Lethality

项目摘要

项目成果

White Justin M的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Many chemotherapies and cancer treatment strategies aim to introduce DNA damage, ideally within the cancer cells and not normal, healthy cells. There are many pathways that cells can leverage to overcome this kind of damage, one of which is known as trans
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapy induced hypermutation to stimulate immune responses in recurrent cancer
  • 批准号：
    415354
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $1.27万
  • 财政年份：
    2018
  • 负责人：
    White Justin M
  • 依托单位：
    University of British Columbia
海外基金